CITADEL ADVISORS LLC 13D and 13G filings for Aura Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:18 pm Sale | 2024-09-30 | 13G | Aura Biosciences, Inc. AURA | CITADEL ADVISORS LLC | 32,626 0.100% | -3,598,868 (-99.10%) | Filing |
| 2024-02-14 4:57 pm Purchase | 2023-12-31 | 13G | Aura Biosciences, Inc. AURA | CITADEL ADVISORS LLC | 3,631,494 7.400% | 894,441 (+32.68%) | Filing |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Aura Biosciences, Inc. AURA | CITADEL ADVISORS LLC | 2,737,053 7.400% | 421,951 (+18.23%) | Filing |
| 2022-02-14 06:26 am Sale | 2021-12-31 | 13G | Aura Biosciences, Inc. AURA | CITADEL ADVISORS LLC | 2,315,102 7.900% | -2,656 (-0.11%) | Filing |
| 2021-11-12 4:07 pm Purchase | 2021-11-02 | 13G | Aura Biosciences, Inc. AURA | CITADEL ADVISORS LLC | 2,317,758 8.200% | 2,317,758 (New Position) | Filing |